Mazdutide: An emerging glucagon GCG like peptide 1 dual receptor agonist for obesitya comparison of therapeutic effects and potential side effects with GCG like peptide 1 inhibitors Cytoprotective gastric pentadecapeptide BPC 157 resolves major vessel occlusion disturbances, ischemia reperfusion injury following Pringle maneuver, and Budd Chiari syndrome Effect of combination treatment with glucagon like peptide 1 receptor agonists and sodium glucose cotransporter 2 inhibitors on incidence of cardiovascular and serious renal events: population based cohort study The BMJ The Impact of Glucagon like Peptide 1 Receptor Agonists on Erectile Function: Friend or Foe?